Mounjaro
FDA ApprovedType 2 Diabetes (off-label for weight loss)
How Mounjaro Works
Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist - the first in its class. Unlike semaglutide-based medications that target only the GLP-1 receptor, tirzepatide activates both GIP and GLP-1 receptors, which may lead to greater appetite reduction and improved blood sugar control. This dual mechanism is believed to explain why tirzepatide produced superior weight loss results compared to semaglutide in head-to-head trials.
In the SURMOUNT-1 trial, patients on the highest dose of tirzepatide (15mg) lost an average of 22.5% of body weight over 72 weeks - the highest weight loss ever achieved by a medication in clinical trials at that time. The 10mg dose produced 19.5% weight loss, and the 5mg dose produced 15% weight loss.
Mounjaro Providers & Pricing
Dosing Schedule
Side Effects
Common
- Nausea (most common during dose escalation)
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Indigestion
- Abdominal pain
Serious (Rare)
- Pancreatitis
- Gallbladder problems
- Hypoglycemia (especially with insulin)
- Kidney problems
- Allergic reactions
- Thyroid C-cell tumors (boxed warning, animal studies)
Insurance & Coverage
Mounjaro is primarily covered by insurance for type 2 diabetes. Off-label weight loss coverage is less common. Eli Lilly has offered savings cards that can bring the cost down to $25/month for commercially insured patients. Without insurance, Mounjaro costs approximately $1,000-$1,200/month.
Brand vs. Compounded
Compounded tirzepatide has become available from compounding pharmacies at significantly lower prices. However, the FDA has been more active in challenging compounded tirzepatide availability. Patients should verify their compounding pharmacy is licensed and uses quality-tested ingredients.
Frequently Asked Questions
How much does Mounjaro cost without insurance?
Mounjaro costs approximately $1,000-$1,200/month without insurance at retail pharmacies. Eli Lilly has offered manufacturer savings cards, and some telehealth providers offer it at reduced rates. Compounded tirzepatide alternatives typically cost $200-$500/month.
Is Mounjaro better than Ozempic for weight loss?
Head-to-head clinical trials showed tirzepatide (Mounjaro's active ingredient) produced greater weight loss than semaglutide (Ozempic/Wegovy). At the highest dose, tirzepatide patients lost 22.5% of body weight vs about 15% for semaglutide. Individual results vary.
Is Mounjaro FDA-approved for weight loss?
Mounjaro is FDA-approved for type 2 diabetes, not weight loss. Zepbound, which contains the same active ingredient (tirzepatide), is the version FDA-approved specifically for chronic weight management.
How is Mounjaro different from Zepbound?
Both contain tirzepatide made by Eli Lilly. Mounjaro is approved for type 2 diabetes, while Zepbound is approved for weight loss. The dosing and active ingredient are identical - the main difference is the FDA indication and how insurance covers each.
Mounjaro by State
Get GLP-1 Price Alerts
Be the first to know when providers drop prices or new options become available.
Other GLP-1 Medications
Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare provider before starting or changing any medication. Side effects, dosing, and eligibility should be discussed with a qualified physician.